Alumis Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ALMS on Nasdaq
Industry
Pharmaceutical Preparations
Location
280 East Grand Avenue, South San Francisco, CA

Insiders trading volume in the past year

Alumis Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
AyurMaya Capital Management Company, LP Director, Other*, 10%+ Owner $170M Jul 1, 2024
James B. Tananbaum Director, 10%+ Owner $67.2M Jul 1, 2024
Foresite Labs, LLC 10%+ Owner $67.2M Jul 1, 2024
Foresite Capital Management V, LLC 10%+ Owner $67.2M Jul 1, 2024
Srinivas Akkaraju Director $52.3M +$25M +91.7% Jul 1, 2024
David M. Goldstein Chief Scientific Officer $3.47M Jul 1, 2024
Roy C. Hardiman Chief Business & Legal Officer $2.91M Jul 1, 2024
Martin Babler President, CEO and Chairman, Director $1.45M Jun 27, 2024
Mark Christopher Bradley Chief Development Officer $672K Jun 27, 2024
Sara Klein General Counsel - Corp Secy $541K Jun 27, 2024
Zhengbin Yao Director $376K Jun 27, 2024
Sapna Srivastava Director Jun 27, 2024
Patrick Machado Director Jun 27, 2024
Derrick Richardson SVP, People and Culture Jun 27, 2024
Jorn Drappa Chief Medical Officer Jun 27, 2024
Alan Colowick Director Jun 27, 2024
John R. Schroer Chief Financial Officer Jun 27, 2024

Recent Insider Transactions by Companies or Individuals for Alumis Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.